Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study probes hidden language struggles in psychosis patients

NCT ID NCT06036316

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at language difficulties in people with psychosis, including those at risk, experiencing a first episode, or diagnosed with schizophrenia. Researchers will give a full language test to 90 patients and compare results with a healthy control group. The goal is to better understand how language problems relate to memory and other symptoms, which could improve future care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 90 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2024

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

16 to 55 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * All Groups: * Patient affiliated or entitled to a social security scheme * Patient having received informed information on the study and having co-signed, with the investigator, a consent to participate in the study * For minor participants, at least one of the parents or holders of parental authority having been informed of the study, having received the information note relating to it and not having objected to the participation of his or her child * Native language: French * ARMS and FEP Patient Group: * Age between 16 and 35 years old * Present the criteria for EMRP or FEP as defined by the Comprehensive Assessment of At Risk Mental State (CAARMS) or present the criteria for Disorders of the course of thought to the items of the Schizophrenia Proneness Instrument (SPI-A) * Patients with schizophrenia group: * Age between 16 and 55 years old * Patient with diagnostic criteria for schizophrenia, as defined by DSM V (American Psychiatric Association, 2015) * Present the criteria for Disorganization of Speech and Formal Thought Disorder as defined by the Thinking, Language and Communication (TLC) Rating Scale. * Healthy Volunteers Group: * Age between 16 and 55 years old * Parental authorization (of both parents) to participate in the study for minor patients Exclusion Criteria: * All groups: * Pregnant, parturient or nursing mother * Person deprived of liberty by a judicial or administrative decision * Person in a life-threatening emergency * Adult subject to a legal protection measure (guardianship, curatorship, safeguard of justice) * Adult person unable to express their consent and who is not the subject of a legal protection measure * Impairment of the subject making it difficult, if not impossible, for them to participate in the trial or to understand the information given to them * Abuse or dependence of any substance according to DSM V criteria excluding cannabis * Healthy Volunteers Group: * Evolving psychiatric pathology (axis I of the DSM IV, measured at the MINI) excluding anxiety disorder * Presence of developmental disorder of oral language or written language revealed on clinical examination.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for At-risk mental state are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Centre Psychothérapeutique de Nancy

    RECRUITING

    Laxou, France, 54520, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.